These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 12649296

  • 21. Effect of galantamine on the human alpha7 neuronal nicotinic acetylcholine receptor, the Torpedo nicotinic acetylcholine receptor and spontaneous cholinergic synaptic activity.
    Texidó L, Ros E, Martín-Satué M, López S, Aleu J, Marsal J, Solsona C.
    Br J Pharmacol; 2005 Jul; 145(5):672-8. PubMed ID: 15834443
    [Abstract] [Full Text] [Related]

  • 22. [Mechanisms of action of Alzheimer medications].
    Alhainen K.
    Duodecim; 2003 Jul; 119(20):1959-66. PubMed ID: 14640001
    [No Abstract] [Full Text] [Related]

  • 23. Comparison of galantamine and donepezil for effects on nerve growth factor, cholinergic markers, and memory performance in aged rats.
    Hernandez CM, Gearhart DA, Parikh V, Hohnadel EJ, Davis LW, Middlemore ML, Warsi SP, Waller JL, Terry AV.
    J Pharmacol Exp Ther; 2006 Feb; 316(2):679-94. PubMed ID: 16214877
    [Abstract] [Full Text] [Related]

  • 24. Regulation of nicotinic acetylcholine receptor channel function by acetylcholinesterase inhibitors in rat hippocampal CA1 interneurons.
    Fayuk D, Yakel JL.
    Mol Pharmacol; 2004 Sep; 66(3):658-66. PubMed ID: 15322258
    [Abstract] [Full Text] [Related]

  • 25. Donepezil, but not galantamine, blocks muscarinic receptor-mediated in vitro and in vivo responses.
    Ago Y, Koda K, Ota Y, Kita Y, Fukada A, Takuma K, Matsuda T.
    Synapse; 2011 Dec; 65(12):1373-7. PubMed ID: 21780184
    [Abstract] [Full Text] [Related]

  • 26. The new cholinesterase inhibitors for Alzheimer's disease, Part 2: illustrating their mechanisms of action.
    Stahl SM.
    J Clin Psychiatry; 2000 Nov; 61(11):813-4. PubMed ID: 11105732
    [No Abstract] [Full Text] [Related]

  • 27. Pharmacokinetic and pharmacodynamic properties of cholinesterase inhibitors donepezil, tacrine, and galantamine in aged and young Lister hooded rats.
    Goh CW, Aw CC, Lee JH, Chen CP, Browne ER.
    Drug Metab Dispos; 2011 Mar; 39(3):402-11. PubMed ID: 21148081
    [Abstract] [Full Text] [Related]

  • 28. [Pharmacological profiles of galantamine: the involvement of muscarinic receptor].
    Matsuda T, Ago Y, Takuma K.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2012 Feb; 32(1):1-8. PubMed ID: 22568120
    [Abstract] [Full Text] [Related]

  • 29. Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy.
    Wilkinson DG, Francis PT, Schwam E, Payne-Parrish J.
    Drugs Aging; 2004 Feb; 21(7):453-78. PubMed ID: 15132713
    [Abstract] [Full Text] [Related]

  • 30. Methamidophos transiently inhibits neuronal nicotinic receptors of rat substantia nigra dopaminergic neurons via open channel block.
    Di Angelantonio S, Bernardi G, Mercuri NB.
    Neurosci Lett; 2004 Oct 21; 369(3):208-13. PubMed ID: 15464266
    [Abstract] [Full Text] [Related]

  • 31. Inhibition mechanism of rat α₃β₄ nicotinic acetylcholine receptor by the Alzheimer therapeutic tacrine.
    Cheffer A, Ulrich H.
    Biochemistry; 2011 Mar 22; 50(11):1763-70. PubMed ID: 21247200
    [Abstract] [Full Text] [Related]

  • 32. Effects of galantamine, a nicotinic allosteric potentiating ligand, on nicotine-induced catecholamine release in hippocampus and nucleus accumbens of rats.
    Sharp BM, Yatsula M, Fu Y.
    J Pharmacol Exp Ther; 2004 Jun 22; 309(3):1116-23. PubMed ID: 14769831
    [Abstract] [Full Text] [Related]

  • 33. Mechanism of neuroprotection by donepezil pretreatment in rat cortical neurons chronically treated with donepezil.
    Takada-Takatori Y, Kume T, Ohgi Y, Izumi Y, Niidome T, Fujii T, Sugimoto H, Akaike A.
    J Neurosci Res; 2008 Dec 22; 86(16):3575-83. PubMed ID: 18655200
    [Abstract] [Full Text] [Related]

  • 34. Galantamine activates muscle-type nicotinic acetylcholine receptors without binding to the acetylcholine-binding site.
    Akk G, Steinbach JH.
    J Neurosci; 2005 Feb 23; 25(8):1992-2001. PubMed ID: 15728839
    [Abstract] [Full Text] [Related]

  • 35. Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer's disease.
    Maelicke A, Samochocki M, Jostock R, Fehrenbacher A, Ludwig J, Albuquerque EX, Zerlin M.
    Biol Psychiatry; 2001 Feb 01; 49(3):279-88. PubMed ID: 11230879
    [Abstract] [Full Text] [Related]

  • 36. Nicotinic component of galantamine in the regulation of amyloid precursor protein processing.
    Lenzken SC, Lanni C, Govoni S, Lucchelli A, Schettini G, Racchi M.
    Chem Biol Interact; 2007 Jan 30; 165(2):138-45. PubMed ID: 17196952
    [Abstract] [Full Text] [Related]

  • 37. Galantamine-induced amyloid-{beta} clearance mediated via stimulation of microglial nicotinic acetylcholine receptors.
    Takata K, Kitamura Y, Saeki M, Terada M, Kagitani S, Kitamura R, Fujikawa Y, Maelicke A, Tomimoto H, Taniguchi T, Shimohama S.
    J Biol Chem; 2010 Dec 17; 285(51):40180-91. PubMed ID: 20947502
    [Abstract] [Full Text] [Related]

  • 38. Cholinesterase inhibitors in the treatment of dementia.
    Ellis JM.
    J Am Osteopath Assoc; 2005 Mar 17; 105(3):145-58. PubMed ID: 15863734
    [Abstract] [Full Text] [Related]

  • 39. [Nicotinic Receptor, galantamine and Alzheimer disease].
    Arroyo G, Aldea M, Fuentealba J, García AG.
    Rev Neurol; 2005 Mar 17; 34(11):1057-65. PubMed ID: 12134305
    [Abstract] [Full Text] [Related]

  • 40. Modulation of N-methyl-D-aspartate receptors by donepezil in rat cortical neurons.
    Moriguchi S, Zhao X, Marszalec W, Yeh JZ, Narahashi T.
    J Pharmacol Exp Ther; 2005 Oct 17; 315(1):125-35. PubMed ID: 15951396
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.